Skip to main content

Table 4 Uni- and multivariate analysis of preoperative risk factors for recurrence among all HCC cases who survived more than 6 months after initial hepatectomy

From: Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma

 

Univariate analysis

Multivariate analysis

 

HR (95% CI)

p value

HR (95% CI)

p value

Age

1.02 (1.00–1.04)

0.078

  

Gender (Male / Female)

0.82 (0.52–1.30)

0.40

  

BMI

0.97 (0.92–1.02)

0.21

  

Albumin (g/dL)

0.70 (0.48–1.02)

0.06

  

Total bilirubin (mg/dL)

1.15 (0.66–2.01)

0.64

  

PT-INR

6.18 (1.23–31.10)

0.027

  

Platelet count (× 104/μL)

1.00 (0.99–1.01)

0.46

  

AFP (ng/mL)

1.00 (1.00–1.00)

0.63

  

DCP (mAU/mL)

1.00 (1.00–1.00)

0.44

  

ICG R15 (%)

1.04 (1.00–1.03)

0.061

  

LHL15

0.019 (0.00–0.75)

0.034

0.019 (0.00–0.75)

0.034

PNI

0.96 (0.93–0.99)

0.013

  

Underlying liver disease

NBNC / HBV / HCV

0.69 (0.47–1.00)

0.05*

  

Maximum tumor diameter (cm)

1.03 (0.98–1.08)

0.25

  

Multiple tumor nodules

1.41 (0.93–2.15)

0.11

  

BCLC stage 0/A/B/C

2.37 (1.16–4.82)

0.018**

  

Up-to-7 criteria out

1.29 (0.88–1.89)

0.20

  

5–5-500 criteria out

1.01 (0.71–1.44)

0.97

  

Anatomical resection

0.84 (0.59–1.21)

0.35

  

Laparoscopic

1.23 (0.80–1.89)

0.35

  
  1. BMI body mass index, PT-INR prothrombin time-international normalized ratio, AFP alpha fetoprotein, DCP des-γ-carboxyprothrombin, ICG R15 indocyanine green retention rate at 15 min, LHL15 GSA uptake ratio of the liver to the liver plus heart at 15 min, PNI prognostic nutritional index, NBNC Non-B non-C, HBV hepatits B, HCV hepatitis C, BCLC stage Barcelona Clinic Liver Cancer stage
  2. *The risk of NBNC to HCV
  3. **The risk of BCLC stage B to stage 0